IMI chief: ‘We need to learn how to share data in a safe and ethical manner’

By |april 7th, 2017|alzheimer's, Antimicrobial resistance, asthma, biomedicines, Biotechnology, cancer, medicines, News, rare diseases, World Health Organisation|

Ethicists, humanists, lawyers and patients should come together to understand the risk of data in healthcare and whether patients are willing to take that risk, Pierre Meulien told EURACTIV.com.